Navigation Links
Severe COPD may lead to cognitive impairment
Date:7/7/2009

Severe chronic obstructive pulmonary disease (COPD) is associated with lower cognitive function in older adults, according to research from Mount Sinai School of Medicine. Researchers compared cognitive performance in over 4,150 adults with and without COPD and found that individuals with severe COPD had significantly lower cognitive function than those without, even after controlling for confounding factors such as comorbidities.

The results were published in the July 15 issue of the American Journal of Respiratory and Critical Care Medicine.

"Our findings should raise awareness that adults with severe COPD are at greater risk for developing cognitive impairment, which may make managing their COPD more challenging, and will likely further worsen their general health and quality of life," wrote lead author of the study, William W. Hung, M.D., M.P.H., assistant professor at Mount Sinai School of Medicine.

Patients with COPD may experience periods of hypoxialow oxygen levelsthat might lead to brain abnormalities that could reduce cognitive capacity. Alternatively, hypoxia may cause or exacerbate diseases that are characterized by cognitive impairment, such as Alzheimer's disease. Although past studies have observed a higher rate of cognitive impairment among adults with COPD, the relationship has not been formally tested longitudinally in large populations until now.

"We wanted to determine whether the observed relationship between COPD and cognitive impairment was, in fact, something we could document over time, and if so, we wanted to determine whether the degree to which it occurred was significant," said Dr. Hung.

To do so, Dr. Hung and colleagues obtained data from the Health and Retirement Study, a national prospective biennial survey of Americans 50 and older. They included data from survey takers who had undergone cognitive testing in 1996 and again in 1998, 2000 or 2002.

Of the 4,150 individua
'/>"/>

Contact: Keely Savoie
kgsavoie@gmail.com
315-212-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Antidepressants aid electroconvulsive therapy in treating severe depression
2. Patients with moderate to severe periodontitis need evaluation for heart disease risk
3. NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain
4. Generation of a severe memory-deficit mutant mouse by exclusively eliminating the kinase activity of CaMKIIalpha
5. Physiological response may explain why some severely obese patients overeat
6. Severe Nightmares May Warn of Suicidal Symptoms
7. MDCT angiography leads to successful treatment of severely blocked arteries in the legs
8. Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications
9. Cottonseed-based drug shows promise in treating severe brain cancer
10. IBI Research Finds Employers Severely Underestimate the Prevalence and Lost Productivity Costs of Depression
11. Perforomist(R) Inhalation Solution Data in Patients With Moderate to Severe COPD to Be Presented at the International Conference of the American Thoracic Society
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Cephalon Quarterly Conference Call Invitation 12853 1Police work undermines cardiovascular health comparison to general population shows 50430 1Police work undermines cardiovascular health comparison to general population shows 50430 2Police work undermines cardiovascular health comparison to general population shows 50430 3Bladder Cancer No Longer a Death Sentence 50427 1Bladder Cancer No Longer a Death Sentence 50427 2Bladder Cancer No Longer a Death Sentence 50427 3